Mechanical ventilation activates PERK/eIF2α and NOD1 pathways that contribute to NF-κB–driven inflammation in VILI Authors: Maoyao Ling, Yalan Jiang, Umut Cakir, Kejian Lu, Xiaoting Liao, Guiting Yang, Liu Ji, Tingting Meng, Cuiyuan Huang, Liu Ye, Linghui Pan Published: 2026 ABSTRACT AbstractBackgroundVentilator-induced lung injury (VILI) is characterized by acute lung damage and NF-κB–driven cytokine production during mechanical ventilation. However, the upstream signals that initiate and exacerbate NF-κB-driven inflammation remain poorly understood. Although endoplasmic reticulum (ER) stress is implicated in VILI, how ER stress pathways interact with innate immune sensors to promote inflammation is incompletely defined. Here, we investigate the roles of NOD1 and the ER stress–responsive PERK/eIF2α pathway in a VILI mice model. MethodsC57BL/6 mice were subjected to high-tidal volume (HTV) ventilation for 4 h to establish an in vivo model of VILI. To investigate the role of NOD1 in VILI, Nod1-knockout (Nod1-KO) mice were generated. To further determine the involvement of the PERK pathway, wild-type and Nod1-KO mice were treated with PERK inhibitor GSK2606414 prior to HTV ventilation. Lung injury was evaluated using H&E staining, wet/dry ratio, and analysis of bronchoalveolar lavage fluid (BALF) for total protein concentration and inflammatory cell counts. Inflammatory cytokine levels were quantified by ELISA. Relative proteins expression was analyzed by immunoblotting and immunofluorescence.ResultsHTV ventilation induced lung histopathological damage, alveolar-capillary barrier dysfunction, and increased levels of IL-1β, IL-6, and TNF-α, along with upregulation of NOD1 and the ER stress marker GRP78. Genetic deletion of Nod1 attenuated lung injury and inflammatory cytokine release, associated with reduced GRP78 abundance and decreased NF-κB activation. In parallel, HTV increased phosphorylation of PERK and eIF2α, and pharmacological inhibition of PERK with GSK2606414 ameliorated lung injury and inflammation while suppressing NF-κB activation, without altering NOD1 protein abundance. Notably, combining NOD1 deficiency with PERK inhibition produced more pronounced protection against HTV-induced lung injury than either intervention alone, whereas the reduction of NF-κB readouts did not further deepen under the combined condition.ConclusionsHTV-induced inflammatory lung injury is associated with activation of both NOD1 and PERK/eIF2α signaling. Mechanistically, these pathways contribute to NF-κB-associated inflammatory responses and lung injury in VILI. Notably, the greater protection observed under combined NOD1 deficiency and PERK inhibition, despite a plateau in NF-κB readouts, suggests that additional injury mechanisms beyond NF-κB may also be involved.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12931-026-03745-9.Keywords: Ventilator-induced lung injury, Endoplasmic reticulum stress, Nucleotide-binding oligomerization domain-containing protein 1, Protein kinase R-like endoplasmic reticulum kinase, NF-κB signaling pathway Background Mechanical ventilation is indispensable for the management of patients with acute respiratory distress syndrome (ARDS), yet prolonged or excessive tidal volumes can precipitate or aggravate ventilator-induced lung injury (VILI), a complication strongly associated with increased morbidity and mortality [1, 2]. VILI is characterized by disruption of the alveolar-capillary barrier, pulmonary edema, inflammatory-cell infiltration, and a prominent sterile inflammatory response. In this process, nuclear factor-kappa B (NF-κB) serves as a central transcriptional regulator that governs the expression of numerous inflammatory mediators, including interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) [3–6]. Despite extensive investigation, the upstream signaling events that initiate and sustain NF-κB–dependent inflammation during mechanical stress remain incompletely understood. Endoplasmic reticulum (ER) stress has emerged as an important contributor to sterile inflammation in multiple organ injury contexts, including lung injury [7–9]. Under homeostatic conditions, the ER chaperone glucose-regulated protein 78 (GRP78) suppresses three major unfolded protein response (UPR) sensors—protein kinase R (PKR)-like ER kinase (PERK), inositol-requiring protein 1α (IRE-1α), and activating transcription factor 6 (ATF6). Upon ER stress, GRP78 dissociates, leading to activation of all three UPR branches [10]. While adaptive UPR activation can restores ER homeostasis, sustained or excessive ER stress may promote inflammatory transcription programs, oxidative stress, and cell injury [11, 12]. Among UPR branches, PERK phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2α), triggering translational reprogramming and integrated stress responses that can intersect with inflammatory signaling networks. PERK/eIF2α signaling has been linked to NF-κB activation in several inflammatory settings [13, 14], yet its contribution to VILI-associated inflammatory amplification and its relationship to innate immune sensors remain to be clarified. Innate immune pattern-recognition receptors (PRRs) represent another major gateway to NF-κB activation in sterile and infectious inflammation [15, 16]. Among these, Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD)-like receptors can be engaged by pathogen-associated ligands as well as by endogenous danger signals released during tissue stress [6]. NOD1, a cytosolic PRR best known for sensing bacterial peptidoglycan motifs, signals through downstream adaptors to activate NF-κB and mitogen-activated protein kinase (MAPK) pathways [17, 18]. Beyond classical infection paradigms, NOD1 has also been implicated in sterile inflammation and metabolic or stress-related disorders, suggesting that its activity may be shaped by cellular stress states [19, 20]. However, whether NOD1 is induced and functionally required in VILI, and how it relates to ER stress–responsive signaling during injurious ventilation, remain poorly defined. Recent studies indicate that the PERK/eIF2α/ATF4/CHOP pathway contributes to epithelial injury in mechanically ventilated lungs [21–23]. PERK activation suppresses global protein translation yet selectively inducing activating transcription factor 4 (ATF4) and C/EBP homologous protein (CHOP), and prolonged activation of this pathway ultimately drives inflammation and apoptosis [24, 25]. Importantly, emerging data show that PERK/eIF2α signaling activates NF-κB by reducing translation of its inhibitor IκBα, thereby promoting inflammatory gene expression [13, 14, 26]. Nevertheless, the relationship between the ER stress-PERK branch and NOD1 signaling during VILI has not been elucidated. Specifically, it remains unclear whether PERK regulates NOD1 activation, whether these two pathways interact directly, or whether they operate independently to amplify inflammation. Clarifying this relationship may provide new insight into the mechanisms of inflammatory amplification during mechanical ventilation and represents a novel aspect of the present study. Based on these observations, we hypothesized that mechanical ventilation activates both PERK/eIF2α and NOD1 signaling, Furthermore, given previous evidence that ER stress can modulate NOD1, we speculated that interactions between these pathways and whether PERK modulate NOD1. In this study, we investigated the contribution of NOD1 and the PERK/eIF2α axis to inflammatory lung injury in a high-tidal-volume(HTV)-induced VILI model. We first determined whether HTV ventilation is associated with changes in NOD1 expression and ER stress markers, then assessed the functional role of NOD1 using NOD1-deficient mice. We then evaluated PERK/eIF2α activation during VILI and tested the impact of pharmacological PERK inhibition on NF-κB activation and lung injury outcomes. Finally, we examined whether combined perturbation of NOD1 and PERK produces enhanced protection. Our findings reveal that both NOD1 and PERK/eIF2α pathways are activated in VILI mice. NOD1 deficiency not only attenuated inflammation but also reduced GRP78 and NF-κB levels. PERK inhibition suppressed NF-κB activation without altering NOD1 expression. Moreover, combining NOD1 deficiency with PERK inhibition produced more pronounced protection against VILI than either intervention alone. Together, these results indicate that PERK and NOD1 act as upstream regulators converging on of NF-κB–dependent sterile inflammation in VILI, which highlights the potential therapeutic benefit of targeting both pathways simultaneously. Methods Reagents PERK inhibitor GSK2606414 was purchased from MedChemExpress (MCE, USA). RNAiso Reagent, PrimeScript™ RT reagent kit, and TB Green® Premix Ex Taq™ kit were provided by Takara (Japan). BCA protein assay kits and Nuclear and Cytoplasmic Protein Extraction Kit were acquired from Beyotime (China). RIPA buffer and protease inhibitors were supplied by Solarbio (China). ELISA kits for IL-1β, IL-6, and TNF-α were purchased from Cusabio (China) or Upingbio (China). NOD1 (ab215726, Abcam), GRP78 (sc-166490, Santa Cruz), phospho-PERK (PA5-102853, ThermoFisher), PERK (#5683, Cell Signaling Technology), phospho-eIF2α (AP0635, ABclonal), eIF2α (A0764, ABclonal), IκBα (#4814s, CST), NF-κB p65 (#8242s, CST), Lamin B (sc-374015, Santa Cruz), and β-actin (#4970, CST) were used as primary antibodies. HRP-conjugated secondary antibodies and ECL detection kits were from Beyotime (China) and MCE (USA). DyLight-conjugated secondary antibodies were purchased from CST (USA). Fluorophore-conjugated secondary antibodies (Alexa Fluor 488/546) and DAPI were obtained from Invitrogen (USA). The specific primers of Nod1, and β-actin were synthesized and provided by Sangon Biotech (China). Animals All experiments were conducted in accordance with established guidelines and were approved by The Animal Care & Welfare Committee of Guangxi Medical University. The Male C57BL/6 wild-type (WT) mice (weighing 25 ± 2 g) were obtained from the Animal Center of Guangxi Medical University (Nanning, China). The C57BL/6 N Nod1-KO (Nod1−/−) mice were purchased from the Cyagen (Suzhou, China). All mice were maintained under specific pathogen-free condition of 22 ℃ ± 2 ℃ and a 12 h:12 h light/dark cycle, with free access to food and water. VILI model The animal model was established based on previous studies [27, 28]. Briefly, mice were anesthetized with sodium pentobarbital (60 mg/kg), and subsequently mice were administrated with a quarter of the initial dose of pentobarbital at 45 min intervals to maintain anesthesia. Next, animals were orotracheally intubated with a sterilized 20G plastic catheter (Cusabio, China) and then connected to animal ventilator for ventilation (catalogno.SAR-1000, CWE). The ventilation rate was set at 80 breaths/min, with the fraction of inspired oxygen at approximately 40–50%. Meantime, the inspiration-to-expiration ratio was maintained at 1:1, and positive end expiratory pressure of zero. Treated mice were mechanically ventilated with HTV (20 mL/kg) for 4 h, and control mice underwent orotracheal intubation while breathed spontaneously. To verify the role of PERK in VILI, 50 mg/kg body weight of PERK inhibitor GSK2606414 (MCE, USA) was intraperitoneally injected to animals 0.5 h before mechanical ventilation. H&E staining for lung histopathology analysis The right lower lung lobe was dissected and fixed with 4% formaldehyde for 24 h (Sigma, MO, USA) before embedded in paraffin. Lung paraffin Sect. (4 μm) were mounted on Superfrost Plus microscope slides (Thermo, Waltham, MA). After deparaffinization, the sections were stained with hematoxylin-eosin (H&E) for histology. The degree of lung injury was estimated by using standard protocols for acute lung injury scores reported previously [29]. W/D weight ratio of lung tissue Lung W/D weight ratio was obtained to evaluate pulmonary edema. The middle lobe of the right lung was surgically excised. The moisture of the lung surface was carefully absorbed using a gauze, and the wet weight of the lungs was obtained. Subsequently, the lungs were dried at 60 °C for 48 h to a consistent weight, then the dry weight was obtained. Assessment of inflammatory response Pulmonary permeability was assessed by measuring protein concentration in the BALF supernatant using a bicinchoninic acid (BCA) assay (Beyotime, China). Cells in the BALF were counted with a hemocytometer to evaluate inflammatory infiltration. The concentration of IL-1β, IL-6 and tumor necrosis factor-alpha (TNF-α) in the BALF or lung tissue homogenates was measured using ELISA kits (Cusabio, China; or upingbio, China) following to the manufacturer’s protocols. Quantitative real-time PCR (qRT-PCR) Total RNA was isolated from lung tissue using RNAiso Reagent (Takara Bio, Japan). Reverse transcription and subsequent qRT-PCR were performed using a PrimeScript™ RT reagent kit and a TB Green® Premix Ex Taq™ kit (Takara, Japan), respectively, following the manufacturers’ protocols. The primer were synthesized and provided by Sangon Biotech, sequences were as follows: Nod1, forward: 5’-CGTCAACCAGATCACCGACA-3’, Nod1, forward: 5’-CGTCAACCAGATCACCGACA-3’, reverse: 5’-TGCTTGAGGCCTCTGCATTC-3’; reverse: 5’-TGCTTGAGGCCTCTGCATTC-3’; β-actin, forward: 5’-CCACGACAAGGAGCTGCTTCTG-3’, β-actin, forward: 5’-CCACGACAAGGAGCTGCTTCTG-3’, reverse: 5’-ACCCTGTCCGCCATCACATCA-3’; reverse: 5’-ACCCTGTCCGCCATCACATCA-3’; β-actin was used as internal controls. We employed the 2−△△Ct method for quantification. Western blot analysis Proteins extraction from the lungs was performed using RIPA buffer (Solarbio, China) supplemented with protease inhibitors (Solarbio, China). Nuclear and cytoplasmic proteins were extracted using the Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime, China). Protein concentrations were determined using a BCA assay. Equal amounts of protein were loaded onto a 10% SDS polyacrylamide gel and transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, USA). Membranes were blocked with 5% milk in TBST for 1 h at room temperature and then incubated with the following antibodies: anti-NOD1 (ab-215726,abcam), anti-GRP78 (sc-166490, Santa Cruz), anti-phospho-PERK (PA5-102853, Thermofisher), anti-PERK (#5683, CST), anti-phospho-eIF2α (AP0635, ABclonal), anti-eIF2α (A0764, ABclonal), anti-IκBα (#4814s, CST), anti-NF-κB p65 (#8242s, CST), anti-Lamin B (sc-374015, Santa Cruz) and anti-β-actin (#4970, CST). All primary antibodies were diluted 1:1000 and incubated overnight at 4 °C, following by further incubation with secondary antibodies. For enhanced chemiluminescence (ECL) detection, HRP-conjugated goat anti-rabbit or anti-mouse IgG (1:2000; Beyotime, China) was used, followed by development with ECL kit (MCE, USA) and captured with a Universal Hood (Bio-Rad, USA). For two-color infrared fluorescent detection, membranes were incubated with anti-rabbit IgG (H + L) (DyLight 680 Conjugate) or anti-mouse IgG (H + L) (DyLight 800 Conjugate), both diluted at 1:15000 (CST, USA) and then imaged using an Odyssey® CLx system (LI-COR, USA). All secondary antibody incubations were performed for 1 h at room temperature. Immunofluorescence The slides from the paraffin-embedded lung tissues were deparaffinized and rehydrated. After antigen retrieval, the tissues were blocked with 2% bovine serum albumin in PBS for 1 h. The slides were then incubated overnight at 4 °C with primary antibodies for phospho-PERK (1:200) and phospho-eIF2α (1:200). Subsequently, the slides were washed with three 5-min PBST then incubated at room temperature in the dark for 2 h staining with fluorophore-conjugated secondary antibodies (Alexa Fluor 488–546 nm, Invitrogen, USA) diluted 1:500. DAPI (Invitrogen, USA) was applied for nuclear staining. Following another wash with PBST, the slides were visualized using fluorescence microscopy (Leica, Germany). Statistical analysis Statistics were performed using the Prism 10 software (GraphPad Software, San Diego, CA, USA). Data is presented as mean ± standard deviation (SD) throughout. Shapiro-Wilk test was used for normality. Two-group comparisons were analyzed with Students t-test, whereas differences among multiple groups were compared using one-way analysis of variance followed by the LSD method. A value of P < 0.05 was considered statistically significant. Results Ventilator-induced lung injury is associated with activation of ER stress and upregulation of NOD1 A HTV ventilation model was established to evaluate lung injury and the activation of ER stress and NOD1 signaling. Mice subjected to HTV exhibited pronounced histopathological injury, including-septal thickening, inflammatory-cell infiltration, and pulmonary edema (Fig. 1A-B). Lung water content (W/D ratio), infiltrated cell counts and protein concentration of BALF, and levels of IL-1β, IL-6, and TNF-α were significantly increased in HTV-ventilated mice compared with spontaneously breathing controls (Fig. 1C-H). HTV ventilation induces lung injury, inflammation, activates ER stress and upregulates NOD1. A Representative H&E staining of lung tissues in CON and HTV group. Scale bar: 200 μm. B Pathological scores were determined based on the results of H&E staining. C Lung wet/dry ratio. D Infiltrated cell counts in BALF. E Total protein concentration in BALF. F-H Levels of IL-1β (F), IL-6 (G), and TNF-α (H) in BALF measured by ELISA. I Representative Western blot images of NOD1, GRP78, and β-actin. J-K The relative ratio of GRP78 (J) and NOD1 (K) protein expression normalized to β-actin. Data are expressed as means ± SD (n = 6 per group) Immunoblot analysis revealed a marked increase in NOD1 protein expression in the lungs of HTV-treated mice (Fig. 1I-J). Consistently, GRP78 expression was also elevated in HTV-treated mice (Fig. 1I, K), indicating activation of ER stress. These findings confirm successful establishment of the VILI model and demonstrate that both ER stess and NOD1 signaling are upregulated during mechanical ventilation. NOD1 deficiency alleviates lung injury and suppresses ER stess and NF-κB activation To determine the contribution of NOD1 to VILI, NOD1-knockout (Nod1⁻/⁻) mice were examined, qPCR and Western blotting confirmed the downregulation in NOD1 mRNA and protein expression in lung tissues compared with wild-type controls (Fig. 2A–C). Compared with WT HTV groups, Nod1⁻/⁻ mice exposed to HTV displayed markedly reduced lung injury, as evidenced by improved histopathology, decreased W/D ratios, diminished inflammatory cell infiltration, and reduced BALF protein concentrations (Fig. 2D–H). Furthermore, HTV-induced upregulation of the proinflammatory cytokines IL-1β, IL-6, and TNF-α in BALF were significantly attenuated in mice with partial NOD1 depletion (Fig. 2I–K). Reduction of NOD1 further suppressed HTV-induced ER stress, as indicated by reduced GRP78 expression (Fig. 2L–M). Moreover, lung tissues from Nod1⁻/⁻ mice exhibited preserved IκBα protein levels and decreased nuclear accumulation of NF-κB p65 (Fig. 2L–P), indicating inhibition of canonical NF-κB signaling. Collectively, these results indicate that partial NOD1 knockdown protects against VILI by attenuating inflammatory responses and suppressing both ER stress and NF-κB signaling. NOD1 deficiency attenuates ventilator-induced lung injury and associated ER stress. A-C Validation of NOD1 knockout: relative mRNA expression of Nod1(A) and representative Western blot (B) with quantitative analysis (C) of NOD1 protein normalized to β-actin in lung tissue from WT and Nod1−/− mice under basal conditions. D Representative H&E staining of lung tissues from WT and Nod1−/− mice subjected to HTV ventilation. Scale bar: 200 μm. E Pathological scores were determined based on the results of H&E staining. F Lung wet/dry ratio. G Infiltrated cell counts in BALF. H Total protein concentration in BALF. Ι-K Relative expression of IL-1β (I), IL-6 (J) and TNF-α (K) in BALF. L Representative Western blot images of GRP78, IκBα in lung extracts, NF-κB p65 in nucleus and cytoplasm, and β-actin in CON, HTV and Nod1−/− HTV group. M The relative ratio of GRP78 protein expression normalized to β-actin. N The relative ratio of IκBα protein normalized to β-actin. O The relative ratio of NF-κB p65 protein in nucleus normalized to Lamin B. P The relative ratio of NF-κB p65 protein in cytoplasm normalized to β-actin. Data are expressed as means ± SD (n = 6 per group) The PERK/eIF2α pathway is activated during VILI and contributes to NF-κB–mediated inflammation To investigate whether the PERK branch of ER stress participates in VILI, activation of the PERK–eIF2α pathway was examined. HTV ventilation markedly increased GRP78, phosphorylated PERK, and phosphorylated eIF2α in lung tissues (Fig. 3A–D), which was further confirmed by immunofluorescence staining (Fig. 3E–H). Pretreatment with the PERK inhibitor GSK2606414 effectively reduced p-PERK, p-eIF2α, and GRP78 levels, confirming blockade of PERK signaling. ER stess activation involved in VILI via PERK/ eIF2α/NFκΒ pathway. A Representative Western blot images of GRP78, p-PERK, t-PERK, p-eIF2α, t-eIF2α and β-actin proteins in lung tissues from CON, HTV and GSK group. B The relative ratio of GRP78 protein normalized to β-actin. C The relative ratio of p-PERK protein normalized to t-PERK. D The relative ratio of p-eIF2α protein normalized to t-eIF2α. E Immunofluorescence photomicrographs of p-PERK in lung tissues. DAPI was used to stain the nuclei. Scale bar: 50 μm. F Immunofluorescence mean density of p-PERK. G Immunofluorescence photomicrographs of p-eIF2α in lung tissues. DAPI was used to stain the nuclei. Scale bar: 50 μm. H Immunofluorescence mean density of p-eIF2α. Ι Representative immunoblots of IκBα in lung extracts, and NF-κB p65 in nucleus and cytoplasm. J The relative ratio of IκBα protein normalized to β-actin. K The relative ratio of NF-κB p65 protein in nucleus normalized to Lamin B. L The relative ratio of NF-κB p65 protein in cytoplasm normalized to β-actin. Data are expressed as means ± SD (n = 6 per group) HTV ventilation induced IκBα degradation and robust nuclear translocation of NF-κB p65, whereas PERK inhibition restored IκBα and suppressed NF-κB nuclear accumulation (Fig. 3I–L). Together, these data indicate that the PERK/eIF2α axis is activated during VILI and contributes to NF-κB–dependent inflammatory injury. Inhibition of PERK attenuates inflammation without altering NOD1 expression In parallel with its effects on NF-κB activation, PERK inhibition significantly reduced histopathological injury, W/D ratio, BALF protein leakage, cell infiltration, and cytokine production in HTV-ventilated mice (Fig. 4A–H). However, despite these strong anti-inflammatory effects, GSK2606414 treatment did not alter NOD1 protein expression (Fig. 4I–J). These findings suggest that PERK does not regulate NOD1 activation during VILI, implying that the two pathways function independently upstream of NF-κB. GSK2606414 alleviates lung injury of VILI without altering NOD1 expression. A Representative H&E staining of lung tissues in CON, HTV and GSK group. Scale bar: 200 μm. B Pathological scores were evaluated. C W/D ratios of lung tissues. D Infiltrated cell counts in BALF. E Total protein concentration in BALF. Levels of IL-1β (F), IL-6 (G) and TNF-α (H) in BALF measured by ELISA. I Representative Western blot images of NOD1and β-actin. J The relative ratio of NOD1 protein expression normalized to β-actin. Data are expressed as means ± SD (n = 6 per group) NOD1 and PERK act as upstream pathways that cooperatively shape inflammatory injury in VILI To further investigate the interaction between PERK and NOD1 pathways, WT and Nod1-KO mice were pretreated with GSK2606414 prior to HTV ventilation. Both PERK inhibition and NOD1 deficiency alone significantly reduced lung injury, pulmonary edema, and inflammatory cytokine levels. The combined intervention resulted in an even greater reduction in tissue injury and cytokine production compared with either treatment alone (Fig. 5A-F). Combined NOD1 efficiency and GSK2606414 cooperatively shape inflammatory injury in VILI. A-C Levels of IL-1β (A), IL-6 (B) and TNF-α (C) in lung tissue measured by ELISA. D Lung wet/dry weight ratio. E Infiltrated cell counts in BALF. F Total protein concentration in BALF. G Representative immunoblots of IκBα in lung extracts, and NF-κB p65 in nucleus and cytoplasm. H The relative ratio of IκBα protein normalized to β-actin. I The relative ratio of NF-κB p65 protein in nucleus normalized to Lamin B. J The relative ratio of NF-κB p65 protein in cytoplasm normalized to β-actin. Data are expressed as means ± SD (n = 6 per group) Assessment of NF-κB signaling showed that GSK2606414 and NOD1 reduction each partially restored IκBα levels and reduced NF-κB p65 nuclear translocation. However, combined treatment did not further suppress NF-κB activation beyond the effects produced by single interventions (Fig. 5G-J). These results demonstrate that NOD1 and PERK may function as upstream contributors to VILI, converging on NF-κB activation while also likely influencing additional inflammatory and injury pathways. The observation that combined intervention further improved lung injury indices without a proportionally deeper reduction in NF-κB readouts suggests that mechanisms beyond the measured NF-κB axis may contribute to the superior protection. Discussion VILI is a form of lung injury caused or exacerbated by mechanical ventilation, contributing to elevated morbidity and mortality among patients undergoing ventilator therapy [30–34]. “Biotrauma,” characterized by a sterile inflammatory response, is one of the primary mechanisms underlying VILI [35]. Mechanical stress promotes the activation of inflammatory mediators and excessive production of cytokines, leading to adverse effects at both local (lung) and systemic levels and, ultimately, contributing to multiorgan dysfunction [36, 37]. Consistent with previous studies [27, 38], mice ventilated with HTV for 4 h in our model developed overt lung injury, manifested by alveolar-septal thickening, pulmonary edema, infiltration of inflammatory cells, and elevated levels of IL-1β, IL-6, and TNF-α. These observations underscore the importance of elucidating inflammatory mechanisms underlying VILI to identify effective preventive and therapeutic strategies. In this study, we focused on two pathways that plausibly converge on inflammatory amplification: the cytosolic innate immune sensor NOD1 and the ER stress–responsive PERK/eIF2α branch of the UPR. Using an HTV model, we show that HTV-ventilation is associated with increased NOD1 abundance and elevated ER stress marker GRP78, accompanied by activation of NF-κB and increased pro-inflammatory cytokines. Genetic deletion of NOD1 attenuated lung injury and inflammatory cytokine production, which was associated with reduced NF-κB activation. In parallel, HTV increased phosphorylation of PERK and eIF2α, and pharmacological inhibition of PERK improved lung injury phenotypes and dampened NF-κB activation without changing NOD1 protein abundance. Notably, combined NOD1 deficiency and PERK inhibition provided more pronounced protection against HTV-induced injury than either perturbation alone, while NF-κB readouts displayed a “plateau” under the combined condition. NOD1 is an intracellular pattern-recognition receptor that activates innate immune signaling pathways. It is widely expressed in multiple tissues, including the lung, and is implicated in both infectious and sterile inflammatory diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), acute lung injury(ALI)/ ARDS, pneumoconiosis, and asthma [39]. Classically, NOD1 is activated by peptidoglycan (PGN) fragments derived from bacterial cell walls [40]. Upon ligand sensing, NOD1 undergoes conformational changes and self-oligomerization, leading to the recruitment of the downstream adaptor receptor-interacting protein kinase 2 (RIPK2), which ultimately triggering innate inflammatory responses via activation of NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways [41]. However, accumulating evidence indicates that NOD1 can also be activated through PGN-independent pathways. For example, Keestra-Gounder et al. demonstrated that NOD1 activation links ER stress to inflammatory signaling, independently of PGN stimulation. Additionally, separate research revealed that ER stress facilitates the generation of cytosolic sphingosine-1-phosphate (S1P), which binds to the nucleotide-binding domain (NBD) of NOD1/2 and triggers downstream pro-inflammatory cascades [42]. Further evidence demonstrated that activation of the IRE1α/XBP1 pathway promotes NOD1-mediated inflammation, thereby contributing to the progression of hepatic ischemia-reperfusion injury [43]. Collectively, these findings delineate a spectrum of NOD1-driven inflammatory responses that are independent of classical PGN ligands but are facilitated by ER stress-associated danger signals. A key finding of the present study is that NOD1 plays a critical pathogenic role in VILI. We found that HTV ventilation significantly upregulated NOD1 expression in lung tissue, whereas genetic deletion of NOD1 markedly alleviated lung injury, with reduced inflammatory-cell infiltration and decreased expression of IL-1β, IL-6, and TNF-α. Importantly, reduced NOD1 expression restored IκBα levels and inhibited nuclear accumulation of NF-κB p65, indicating that NOD1 contributes to VILI at least in part through activation of the NF-κB inflammatory pathway. These results are consistent with growing evidence that NOD1 is involved not only in microbial sensing, but also in sterile inflammatory responses, making it a relevant mediator in non-infectious lung injury. ER stress is increasingly recognized as a key mediator of inflammatory injury [44–47]. Our previous work demonstrated that the IRE1α/TRAF2 axis plays a pivotal role in VILI by promoting NF-κB activation [9]. However, the contribution of the PERK arm of ER stress to VILI remains unclear. PERK is a central component of the unfolded protein response [48]. Upon dissociation of GRP78 from its ER luminal domain, PERK undergoes homodimerization and autophosphorylation, leading to activation of the cytoplasmic kinase domain. Activated PERK subsequently phosphorylates eIF2α, resulting in global suppression of translation and transcription of cytoprotective factors. Downstream of eIF2α signaling, a selected group of proteins that includes ATF4 and CHOP are upregulated. Notably, under sustained ER stress, high levels of CHOP can promote apoptosis by increasing protein synthesis, enhancing protein misfolding, promoting oxidative stress, and ultimately driving cell death [49–51]. PERK also plays a role in transmitting mechanosensory signals to the alveolar epithelium [21, 22]. In line with these findings, we observed robust activation of the PERK/eIF2α pathway during HTV ventilation, and pharmacological inhibition of PERK attenuated lung histopathology, reduced cytokine production, and prevented NF-κB nuclear translocation. These results indicate that the PERK branch of ER stress is an important upstream driver of NF-κB-mediated inflammation in VILI. NF-κB is a major transcription factor that regulates genes involved in both innate and adaptive immune responses, and aberrant NF-κB activation contributes to a wide range of inflammatory diseases by promoting the transcription and secretion of pro-inflammatory mediators [52]. In our study, activation of both NOD1 and PERK/eIF2α converged on the NF-κB pathway. Recent work has further suggested that ER stress-PERK activation can enhance NOD1-induced NF-κB signaling [53]. This raised the question of whether NOD1 activation in VILI is mediated by PERK, ultimately leading to NF-κB-dependent inflammation. Surprisingly, however, we found that in our VILI model, PERK inhibition did not alter NOD1 protein levels, suggesting that PERK-dependent effects on inflammation do not require changes in NOD1 expression levels. However, changes in NOD1 abundance do not necessarily capture NOD1 pathway activation status; thus, we cannot exclude the possibility that PERK signaling modulates NOD1 activity (or vice versa) at the level of post-translational regulation, subcellular localization, or adaptor engagement. This distinction—abundance versus activity—should be addressed in future studies. A key observation is that combined NOD1 downregulation and PERK inhibition provided stronger protection against VILI outcomes than either intervention alone, whereas the degree of NF-κB inhibition did not further deepen under the combined condition. Several non-exclusive explanations may account for this pattern. First, commonly used NF-κB readouts may exhibit limited dynamic range or temporal sensitivity in vivo, and additional suppression may not be captured at the sampled time point. Second, the pharmacologic and genetic perturbations may not fully ablate pathway activity, allowing residual or compensatory signaling to maintain a baseline level of NF-κB activation. Third—and likely more important—the enhanced protection may reflect contributions of injury mechanisms that are not fully represented by the measured NF-κB axis alone. VILI is a multifactorial process in which lung injury severity is shaped not only by inflammatory transcription but also by oxidative stress, alveolar-capillary barrier disruption, inflammatory-cell recruitment, and regulated cell death programs. In our previous work, we demonstrated that ROS-associated ER stress contributes to inflammatory amplification and NF-κB activation during mechanical ventilation [8, 11], supporting the concept that oxidative stress and ER stress form an interconnected injury-amplifying network in VILI. Thus, it is plausible that combined targeting of NOD1 and PERK reduces lung injury not only through shared effects on NF-κB-associated cytokine production, but also through broader suppression of oxidative stress–ER stress burden and its downstream tissue-damaging consequences. In addition, our group has consistently shown that ferroptosis is involved in VILI pathogenesis [5, 27, 38]. We previously reported that Ferrostatin-1 alleviates ventilator-induced lung injury by inhibiting ferroptosis [38], and further demonstrated that capsaicin mitigates VILI by suppressing ferroptosis and maintaining mitochondrial redox homeostasis [5]. More recently, we also showed that ferritinophagy mediated by the AMPK/ULK1 pathway contributes to ferroptosis subsequent to VILI [38]. These findings provide a plausible explanation for why combined NOD1 deficiency and PERK inhibition yields stronger protection despite a plateau in NF-κB readouts: the combined intervention may influence NF-κB-independent injury pathways, including oxidative stress-associated cell death programs such as ferroptosis, in addition to affecting inflammatory signaling. Moreover, the greater reduction in BALF protein concentration, infiltrated cell counts, and wet-to-dry ratio under combined treatment suggests that barrier dysfunction and inflammatory-cell infiltration may also be improved through partially distinct mechanisms. NOD1 signaling may contribute to inflammatory amplification and leukocyte recruitment, whereas PERK/eIF2α signaling may additionally affect stress adaptation, epithelial/endothelial injury, and cell-fate programs. Therefore, the additive protection observed here is compatible with a model in which NOD1 and PERK/eIF2α both converge on NF-κB but also influence parallel injury modules beyond a single inflammatory transcriptional pathway. Importantly, in VILI, activation and infiltration of immune cells and the resultant excessive cytokine levels drive pulmonary inflammation, which in turn initiates inflammatory cascades leading to epithelial and endothelial injury [54]. Nevertheless, the mechanisms underlying this intercellular crosstalk remain largely unclear. Notably, the classical pyroptosis pathway features NLRP3 inflammasome activation followed by caspase-1 activation. NF-κB, as a master transcriptional regulator of inflammation, is required for priming NLRP3, pro-IL-1β, and pro-IL-18 [55]. Since NLRP3/caspase-1 signaling is central to VILI [56, 57], our finding of NF-κB activation in this model points to a possible connection between NF-κB and the pyroptotic pathway. Based on previous findings, the NOD1-mediated activation of the NF-κB inflammatory pathway observed in VILI likely links the fates of immune cells and stromal cells through the NLRP3 inflammasome. We also observed that reduced NOD1 expression was associated with reduced GRP78 abundance in VILI mice. While NOD1 has frequently been reported to be activated downstream of ER stress—for example, via the IRE1α/TRAF2 axis [19], our findings suggest that NOD1 may also indirectly amplify ER stress. Reduced GRP78 in NOD1-reduced mice could reflect less severe injury and inflammatory/oxidative burden secondarily lowering ER stress, rather than a direct regulatory role of NOD1 in ER proteostasis. Further mechanistic studies are needed to clarify whether NOD1 exerts any direct effects on ER homeostasis or whether its impact is mainly mediated through downstream inflammatory mediators. Several limitations of this study should be acknowledged. First, ER stress comprises multiple branches with both overlapping yet distinct downstream effects [58]. Our work focused on the PERK/eIF2α axis, and although our previous studies have implicated ROS-associated ER stress signaling and the IRE1α/TRAF2/NF-κB pathway in VILI [8, 11], the interplay between PERK and other ER stress branches in regulating NOD1 activation and lung injury remains unclear. Second, NOD1 and PERK signaling were evaluated at the whole-lung level, and cell-type-specific contributions were not dissected. Third, we assessed NOD1 expression but not its activation status, such as RIPK2 phosphorylation or NOD1 oligomerization. Fourth, all measurements were obtained at a single 4 h HTV time point, which does not resolve the temporal sequence of ER stress and NOD1 activation or the earliest mechanotransduction events linking mechanical stretch to these pathways. Fifth, although combined NOD1 deficiency and PERK inhibition conferred greater protection than either intervention alone, the NF-κB-independent mechanisms underlying this added benefit were not directly explored. Finally, our observations were made in an acute murine VILI model; further studies in vitro and in more clinically relevant settings are needed to better define the relationship between ER stress and NOD1 signaling in lung injury. In summary, our findings support a convergent stress–inflammatory framework in which both NOD1 signaling and PERK/eIF2α activation contribute to NF-κB–associated cytokine responses and lung injury during HTV ventilation. The enhanced protection observed with combined perturbation suggests the potential value of targeting upstream stress and innate immune signaling as a complementary strategy to mitigate inflammatory injury in VILI. In the context of existing approaches that mainly rely on lung-protective ventilation and broader anti-inflammatory or stress-modulating interventions, these findings provide additional mechanistic support for exploring NOD1- and PERK-related pathways as candidate targets. However, the precise mechanisms of pathway coupling and their relevance in clinically complex lung injury settings remain important avenues for further investigation. Conclusions HTV ventilation activates both NOD1 and the ER stress-PERK/eIF2α pathway, which collectively drive NF-κB activation and contribute to VILI. NOD1 deficiency and PERK inhibition each mitigate VILI, and their combined blockade confers even greater protection, despite a plateau effect at the level of NF-κB activation. These findings highlight the existence of a convergent stress –inflammatory network in VILI and identify NOD1 and PERK as promising therapeutic targets for preventing or attenuating VILI. Supplementary Information Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Acknowledgements We sincerely appreciate the collaborative environment and infrastructure support from the Guangxi Health Commission Key Laboratory of Basic Science and Prevention of Perioperative Organ Disfunction and Guangxi Clinical Research Center for Anesthesiology. Abbreviations Acute respiratory distress syndrome Ventilator-induced lung injury Nuclear factor-kappa B Interleukin-1 beta Interleukin-6 Tumor necrosis factor-alpha Endoplasmic reticulum Unfolded protein response Glucose-regulated protein 78 Inositol-requiring enzyme 1 alpha Protein kinase R-like ER kinase Activating transcription factor 6 Eukaryotic translation initiation factor 2 alpha Pattern-recognition receptors Toll-like receptors Nucleotide-binding oligomerization domain Mitogen-activated protein kinase Adaptor receptor-interacting protein kinase 2 Activating transcription factor 4 C/EBP homologous protein Inhibitor of nuclear factor kappa B alpha High-tidal-volume Chronic obstructive pulmonary disease Acute lung injury Peptidoglycan Authors’ contributions Maoyao Ling designed all the experiments. Maoyao Ling, Yalan Jiang and Umut Cakir performed the major experiments and data analysis and drafted the manuscript. Kejian Lu, Xiaoting Liao and Guiting Yang contributed reagents and materials. Liu Ji, TingTing Meng contributed investigation and methodology, Cuiyuan Huang contributed visualization and formal analysis. Liu Ye and Linghui Pan designed the overall study, review and editing the manuscript, and determined the final version. All authors read and approved the final manuscript. Funding This work was supported by the National Natural Science Foundation of China (82100091), Guangxi Natural Science Foundation (China, 2025GXNSFAA069012), First-class discipline innovation-driven talent program of Guangxi Medical University, Guangxi Zhuang Autonomous Region medical young reserve talents training project, Innovation Project of Guangxi Graduate Education (No. YCBZ2025115). Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The animal study was reviewed and approved by The Animal Care & Welfare Committee of Guangxi Medical University. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Maoyao Ling, Yalan Jiang and Umut Cakir contributed equally to this work and are joint first authors. Liu Ye and Linghui Pan contributed equally to this work and share the corresponding authorship. Contributor Information Liu Ye, Email: yeliu0228@outlook.com. Linghui Pan, Email: panlinghui@gxmu.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.